151 related articles for article (PubMed ID: 15505532)
1. CD10 expression in the female genital tract: does it have useful diagnostic applications?
Oliva E
Adv Anat Pathol; 2004 Nov; 11(6):310-5. PubMed ID: 15505532
[TBL] [Abstract][Full Text] [Related]
2. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
3. CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors.
Ordi J; Romagosa C; Tavassoli FA; Nogales F; Palacin A; Condom E; Torné A; Cardesa A
Am J Surg Pathol; 2003 Feb; 27(2):178-86. PubMed ID: 12548163
[TBL] [Abstract][Full Text] [Related]
4. Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation.
Ordi J; Nogales FF; Palacin A; Márquez M; Pahisa J; Vanrell JA; Cardesa A
Am J Surg Pathol; 2001 Dec; 25(12):1540-5. PubMed ID: 11717545
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract][Full Text] [Related]
6. Combined expression of HOXA11 and CD10 identifies endometriosis versus normal tissue and tumors.
Bergman-Larsson J; Gustafsson S; Méar L; Huvila J; Tolf A; Olovsson M; Pontén F; Edqvist PD
Ann Diagn Pathol; 2022 Feb; 56():151870. PubMed ID: 34844098
[TBL] [Abstract][Full Text] [Related]
7. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
[TBL] [Abstract][Full Text] [Related]
8. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
9. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
[TBL] [Abstract][Full Text] [Related]
10. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
11. The expression and diagnostic utility of p63 in the female genital tract.
Houghton O; McCluggage WG
Adv Anat Pathol; 2009 Sep; 16(5):316-21. PubMed ID: 19700941
[TBL] [Abstract][Full Text] [Related]
12. p16 expression in the female genital tract and its value in diagnosis.
O'Neill CJ; McCluggage WG
Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
[TBL] [Abstract][Full Text] [Related]
13. Calretinin: diagnostic utility in the female genital tract.
Portugal R; Oliva E
Adv Anat Pathol; 2009 Mar; 16(2):118-24. PubMed ID: 19550372
[TBL] [Abstract][Full Text] [Related]
14. CD10 is a marker for normal and neoplastic endometrial stromal cells.
Toki T; Shimizu M; Takagi Y; Ashida T; Konishi I
Int J Gynecol Pathol; 2002 Jan; 21(1):41-7. PubMed ID: 11781522
[TBL] [Abstract][Full Text] [Related]
15. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
Srodon M; Klein WM; Kurman RJ
Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in immunohistochemistry in gynaecological pathology.
McCluggage WG
Histopathology; 2002 Apr; 40(4):309-26. PubMed ID: 11943015
[TBL] [Abstract][Full Text] [Related]
17. CD10 is helpful in detecting occult or inconspicuous endometrial stromal cells in cases of presumptive endometriosis.
Groisman GM; Meir A
Arch Pathol Lab Med; 2003 Aug; 127(8):1003-6. PubMed ID: 12873175
[TBL] [Abstract][Full Text] [Related]
18. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
Youssef MY; Mohamed MA
Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
[TBL] [Abstract][Full Text] [Related]
19. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma.
Chu P; Arber DA
Am J Clin Pathol; 2000 Mar; 113(3):374-82. PubMed ID: 10705818
[TBL] [Abstract][Full Text] [Related]
20. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases.
Bagué S; Rodríguez IM; Prat J
Am J Surg Pathol; 2004 May; 28(5):601-7. PubMed ID: 15105647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
